A study of the pharmacokinetics of new formulation lopinavir/ritonavir in the genital tract and plasma of HIV infected women in pregnancy
Phase 1
- Conditions
- HIV during pregnancyMedDRA version: 8.1Level: LLTClassification code 10020180Term: HIV positive
- Registration Number
- EUCTR2006-006297-23-GB
- Lead Sponsor
- Guy's & St Thomas' NHS Foundation Trust
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Female
- Target Recruitment
- 10
Inclusion Criteria
1) HIV antibody positive
2) 18 years and over
3) pregnant
4) Tolerating a lopinavir/ritonavir based regimen in pregnancy
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
1) Less than 18 years of age
2) Taking medication known to interfere with lopinavir
3) Unable to give informed consent
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method